首页 > 最新文献

Italian Journal of Pediatrics最新文献

英文 中文
Clinical characteristics and predictor analysis of pediatric Mycoplasma pneumoniae pneumonia with small segment molded sputum plugs: a retrospective study. 小儿肺炎支原体肺炎伴小段模塑痰塞的临床特点及预测因素分析:回顾性研究。
IF 3.1 3区 医学 Q1 PEDIATRICS Pub Date : 2025-10-24 DOI: 10.1186/s13052-025-02130-4
Baozhou Hong, Chunfang Li, Sijun He, Jinhua Fu, Dongliang Chen

Background: This study aimed to analyze the clinical characteristics and identify predictive factors associated with small segment molded sputum plugs in pediatric patients with Mycoplasma pneumoniae pneumonia (MPP).

Methods: A retrospective analysis was performed on the clinical data of pediatric patients diagnosed with MPP who underwent bronchoscopy at our hospital between December 2021 and April 2024. Multivariate logistic regression was employed to determine independent predictors of small segment molded sputum plug formation.

Results: Among 116 pediatric patients with MPP who met the study criteria, 48 (41.38%) were found to have small segment molded sputum plugs, while 68 (58.62%) did not. Patients with a history of recurrent respiratory infections, diminished breath sounds, and radiological evidence of atelectasis were significantly more likely to develop molded sputum plugs (P < 0.05). Furthermore, the group with small segment molded sputum plugs exhibited a longer duration of fever (P = 0.025) and elevated levels of procalcitonin (PCT; P = 0.024), alanine aminotransferase (ALT; P = 0.048) and prothrombin time (PT; P = 0.021). Multivariate logistic regression analysis identified a history of recurrent respiratory infections and diminished breath sounds as independent predictors for the development of small segment molded sputum plugs.

Conclusions: A history of recurrent respiratory infections and diminished breath sounds emerged as independent predictors of small segment molded sputum plugs in pediatric MPP. These findings highlight the importance of considering these clinical features during the evaluation of MPP patients to inform diagnostic and therapeutic decision-making. Future studies are warranted to investigate the potential benefits of early detection and intervention on clinical outcomes in pediatric MPP.

背景:本研究旨在分析小儿肺炎支原体肺炎(Mycoplasma pneumoniae pneumonia, MPP)患者小段模塑痰塞的临床特点及预测因素。方法:回顾性分析2021年12月至2024年4月在我院行支气管镜检查的小儿MPP患者的临床资料。采用多元逻辑回归确定小段模塑痰塞形成的独立预测因素。结果:116例符合研究标准的小儿MPP患者中,48例(41.38%)有小段模塑痰塞,68例(58.62%)没有。有反复呼吸道感染史、呼吸音减弱和肺不张影像学证据的患者更有可能出现模塑性痰塞(P结论:反复呼吸道感染史和呼吸音减弱是小儿MPP小段模塑性痰塞的独立预测因素。这些发现强调了在评估MPP患者时考虑这些临床特征的重要性,以便为诊断和治疗决策提供信息。未来的研究有必要调查早期发现和干预对儿科MPP临床结果的潜在益处。
{"title":"Clinical characteristics and predictor analysis of pediatric Mycoplasma pneumoniae pneumonia with small segment molded sputum plugs: a retrospective study.","authors":"Baozhou Hong, Chunfang Li, Sijun He, Jinhua Fu, Dongliang Chen","doi":"10.1186/s13052-025-02130-4","DOIUrl":"10.1186/s13052-025-02130-4","url":null,"abstract":"<p><strong>Background: </strong>This study aimed to analyze the clinical characteristics and identify predictive factors associated with small segment molded sputum plugs in pediatric patients with Mycoplasma pneumoniae pneumonia (MPP).</p><p><strong>Methods: </strong>A retrospective analysis was performed on the clinical data of pediatric patients diagnosed with MPP who underwent bronchoscopy at our hospital between December 2021 and April 2024. Multivariate logistic regression was employed to determine independent predictors of small segment molded sputum plug formation.</p><p><strong>Results: </strong>Among 116 pediatric patients with MPP who met the study criteria, 48 (41.38%) were found to have small segment molded sputum plugs, while 68 (58.62%) did not. Patients with a history of recurrent respiratory infections, diminished breath sounds, and radiological evidence of atelectasis were significantly more likely to develop molded sputum plugs (P < 0.05). Furthermore, the group with small segment molded sputum plugs exhibited a longer duration of fever (P = 0.025) and elevated levels of procalcitonin (PCT; P = 0.024), alanine aminotransferase (ALT; P = 0.048) and prothrombin time (PT; P = 0.021). Multivariate logistic regression analysis identified a history of recurrent respiratory infections and diminished breath sounds as independent predictors for the development of small segment molded sputum plugs.</p><p><strong>Conclusions: </strong>A history of recurrent respiratory infections and diminished breath sounds emerged as independent predictors of small segment molded sputum plugs in pediatric MPP. These findings highlight the importance of considering these clinical features during the evaluation of MPP patients to inform diagnostic and therapeutic decision-making. Future studies are warranted to investigate the potential benefits of early detection and intervention on clinical outcomes in pediatric MPP.</p>","PeriodicalId":14511,"journal":{"name":"Italian Journal of Pediatrics","volume":"51 1","pages":"292"},"PeriodicalIF":3.1,"publicationDate":"2025-10-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12636176/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145573682","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The role of thoracic ultrasound in a rare combination of lung abscess and congenital pulmonary airway malformation (CPAM): case report and brief review. 胸部超声在罕见的肺脓肿合并先天性肺气道畸形(CPAM)中的作用:病例报告及简要回顾。
IF 3.1 3区 医学 Q1 PEDIATRICS Pub Date : 2025-10-23 DOI: 10.1186/s13052-025-01970-4
Antonella Amendolea, Giovanni Gaeta, Gabriele Avino

Background: Congenital Pulmonary Airway Malformation (CPAM) is a rare lung anomaly in pediatric patients, often diagnosed prenatally or postnatally. Although typically asymptomatic, CPAM can present with severe complications such as recurrent infections or lung abscesses. Thoracic ultrasound (LUS) is emerging as a valuable diagnostic tool, offering a non-invasive and radiation-free alternative to traditional imaging.

Case presentation: We present the case of a 2-year-old girl with persistent fever, cervical lymphadenopathy, and elevated inflammatory markers, initially raising suspicion for incomplete Kawasaki disease (KD). Despite the administration of intravenous immunoglobulin (IVIG), the fever persisted, prompting further investigations. Lung ultrasound revealed a 5.5 cm lesion with hyperechoic spots and vascularization, suggestive of a lung abscess associated with CPAM. Diagnosis was confirmed by chest CT, and the patient was successfully treated with targeted antibiotic therapy.

Conclusions: This case highlights the importance of considering CPAM as a differential diagnosis in pediatric patients with persistent fever of unknown origin. It also underscores the potential of lung ultrasound as a non-invasive diagnostic tool, complementing traditional imaging methods, in the management of complex pediatric conditions.

背景:先天性肺气道畸形(CPAM)是一种罕见的儿科肺部异常,通常在产前或产后诊断出来。虽然通常无症状,但CPAM可出现严重的并发症,如复发性感染或肺脓肿。胸部超声(LUS)作为一种有价值的诊断工具,提供了一种非侵入性和无辐射的传统成像替代方法。病例介绍:我们报告一名2岁女孩,持续发烧,颈部淋巴结病变,炎症标志物升高,最初引起不完全川崎病(KD)的怀疑。尽管静脉注射免疫球蛋白(IVIG),发烧仍持续,促使进一步调查。肺超声显示一个5.5厘米的病变,伴有高回声斑点和血管化,提示肺脓肿与CPAM相关。经胸部CT确诊,患者经靶向抗生素治疗成功。结论:本病例强调了将CPAM作为儿科不明原因持续发热患者鉴别诊断的重要性。它还强调了肺超声作为一种非侵入性诊断工具的潜力,补充了传统的成像方法,在复杂儿科疾病的管理中。
{"title":"The role of thoracic ultrasound in a rare combination of lung abscess and congenital pulmonary airway malformation (CPAM): case report and brief review.","authors":"Antonella Amendolea, Giovanni Gaeta, Gabriele Avino","doi":"10.1186/s13052-025-01970-4","DOIUrl":"10.1186/s13052-025-01970-4","url":null,"abstract":"<p><strong>Background: </strong>Congenital Pulmonary Airway Malformation (CPAM) is a rare lung anomaly in pediatric patients, often diagnosed prenatally or postnatally. Although typically asymptomatic, CPAM can present with severe complications such as recurrent infections or lung abscesses. Thoracic ultrasound (LUS) is emerging as a valuable diagnostic tool, offering a non-invasive and radiation-free alternative to traditional imaging.</p><p><strong>Case presentation: </strong>We present the case of a 2-year-old girl with persistent fever, cervical lymphadenopathy, and elevated inflammatory markers, initially raising suspicion for incomplete Kawasaki disease (KD). Despite the administration of intravenous immunoglobulin (IVIG), the fever persisted, prompting further investigations. Lung ultrasound revealed a 5.5 cm lesion with hyperechoic spots and vascularization, suggestive of a lung abscess associated with CPAM. Diagnosis was confirmed by chest CT, and the patient was successfully treated with targeted antibiotic therapy.</p><p><strong>Conclusions: </strong>This case highlights the importance of considering CPAM as a differential diagnosis in pediatric patients with persistent fever of unknown origin. It also underscores the potential of lung ultrasound as a non-invasive diagnostic tool, complementing traditional imaging methods, in the management of complex pediatric conditions.</p>","PeriodicalId":14511,"journal":{"name":"Italian Journal of Pediatrics","volume":"51 1","pages":"291"},"PeriodicalIF":3.1,"publicationDate":"2025-10-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12548106/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145354796","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Difference in anterior fontanelle closure between non-syndromic craniosynostosis and normal controls: a retrospective cross-sectional study. 非综合征性颅缝闭合症与正常人前囟门闭合的差异:一项回顾性横断面研究。
IF 3.1 3区 医学 Q1 PEDIATRICS Pub Date : 2025-10-22 DOI: 10.1186/s13052-025-02125-1
Jinhua Fu, Qijia Zhan, Jiangang Liu, Rui Zhao, Wenbin Jiang

Background: This study aimed to investigate the differences in anterior fontanelle closure time and size between children with non-syndromic craniosynostosis and controls on CT imaging.

Methods: A retrospective cross-sectional study was conducted involving 182 children with non-syndromic craniosynostosis and 2,777 age-matched controls (≤ 36 months). The status, size, and timing of anterior fontanelle closure were compared between the two groups. Receiver Operating Characteristic (ROC) curve analysis was utilized to assess the diagnostic value of anterior fontanelle measurements. Additionally, correlation analysis was performed to determine the relationship between age and fontanelle size.

Results: Patients with craniosynostosis exhibited higher closure rates under 24 months, particularly at 7-9 months (22.7% vs. 3.2%, P < 0.0001) and 10-12 months (50.0% vs. 6.9%, P < 0.0001), but lower closure rates at 25-36 months (80.0% vs. 94.0%, P < 0.01). ROC curve analysis identified an optimal cut-off age for fontanelle closure of 9.5 months in craniosynostosis patients (AUC = 0.85) and 17.5 months in controls (AUC = 0.93). Spearman correlation analysis revealed weaker relationships between age and fontanelle size in craniosynostosis patients compared to controls.

Conclusions: Anterior fontanelle measurements, particularly closure timing and size, have potential as assistant markers for the early identification of craniosynostosis. However, definitive diagnosis requires clinical evaluation and imaging confirmation. These findings underscore the importance of early recognition and intervention in craniosynostosis to prevent complications.

背景:本研究旨在探讨非综合征性颅缝闭闭儿童与对照组在前囟门关闭时间和大小的CT影像上的差异。方法:回顾性横断面研究,纳入182例无综合征性颅缝闭合儿童和2777例年龄匹配的对照组(≤36个月)。比较两组前囟门闭合的状态、大小和时间。采用受试者工作特征(ROC)曲线分析评价前囟门测量的诊断价值。此外,进行相关分析以确定年龄与囟门大小之间的关系。结果:颅缝闭合患者在24个月以下表现出更高的闭合率,特别是在7-9个月时(22.7% vs. 3.2%)。结论:前囟门测量,特别是闭合时间和大小,有可能作为早期识别颅缝闭合的辅助标记。然而,明确的诊断需要临床评估和影像学确认。这些发现强调了早期识别和干预颅缝闭锁以预防并发症的重要性。
{"title":"Difference in anterior fontanelle closure between non-syndromic craniosynostosis and normal controls: a retrospective cross-sectional study.","authors":"Jinhua Fu, Qijia Zhan, Jiangang Liu, Rui Zhao, Wenbin Jiang","doi":"10.1186/s13052-025-02125-1","DOIUrl":"10.1186/s13052-025-02125-1","url":null,"abstract":"<p><strong>Background: </strong>This study aimed to investigate the differences in anterior fontanelle closure time and size between children with non-syndromic craniosynostosis and controls on CT imaging.</p><p><strong>Methods: </strong>A retrospective cross-sectional study was conducted involving 182 children with non-syndromic craniosynostosis and 2,777 age-matched controls (≤ 36 months). The status, size, and timing of anterior fontanelle closure were compared between the two groups. Receiver Operating Characteristic (ROC) curve analysis was utilized to assess the diagnostic value of anterior fontanelle measurements. Additionally, correlation analysis was performed to determine the relationship between age and fontanelle size.</p><p><strong>Results: </strong>Patients with craniosynostosis exhibited higher closure rates under 24 months, particularly at 7-9 months (22.7% vs. 3.2%, P < 0.0001) and 10-12 months (50.0% vs. 6.9%, P < 0.0001), but lower closure rates at 25-36 months (80.0% vs. 94.0%, P < 0.01). ROC curve analysis identified an optimal cut-off age for fontanelle closure of 9.5 months in craniosynostosis patients (AUC = 0.85) and 17.5 months in controls (AUC = 0.93). Spearman correlation analysis revealed weaker relationships between age and fontanelle size in craniosynostosis patients compared to controls.</p><p><strong>Conclusions: </strong>Anterior fontanelle measurements, particularly closure timing and size, have potential as assistant markers for the early identification of craniosynostosis. However, definitive diagnosis requires clinical evaluation and imaging confirmation. These findings underscore the importance of early recognition and intervention in craniosynostosis to prevent complications.</p>","PeriodicalId":14511,"journal":{"name":"Italian Journal of Pediatrics","volume":"51 1","pages":"288"},"PeriodicalIF":3.1,"publicationDate":"2025-10-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12542272/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145345199","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Thermal water inhalation for allergic rhinitis and recurrent respiratory infections: a narrative review of the evidence. 热水吸入治疗变应性鼻炎和复发性呼吸道感染:证据的叙述性回顾。
IF 3.1 3区 医学 Q1 PEDIATRICS Pub Date : 2025-10-22 DOI: 10.1186/s13052-025-02133-1
Attilio Varricchio, Giulia Brindisi, Francesco Paolo Brunese, Maria Daglia, Giulio Dinardo, Lorenzo Drago, Alessandra Gori, Cristiana Indolfi, Matteo Naso, Enrico Tondina, Chiara Trincianti, Antonio Varricchio, Anna Maria Zicari, Michele Miraglia Del Giudice, Giorgio Ciprandi

Allergic rhinitis (AR) and recurrent respiratory infections (RRIs) are common conditions that significantly impact quality of life and healthcare systems. Thermal water inhalation therapies have emerged as a potential non-pharmacological option due to their immunomodulatory and anti-inflammatory properties. This narrative review aimed to evaluate the efficacy and safety of thermal water inhalations in managing patients with AR and RRIs. The inclusion criteria were pertinent articles written in English and published in journals listed in PubMed. Six studies conducted in Italy, involving 548 participants (most of whom were children and adolescents), met the inclusion criteria. Significant improvements were observed in nasal mucociliary transport time, with reductions ranging from 2 to 8 min across treatment groups. Total Symptom Scores decreased significantly (one study reported a > 50% reduction). The frequency and duration of upper respiratory tract infections were reduced considerably in the treatment groups compared to the controls. However, results for nasal cytology were inconsistent, and heterogeneity in study designs limited comparability. The reviewed studies highlighted the potential of thermal water therapies to enhance mucociliary clearance, alleviate symptoms, and reduce reliance on other pharmacological treatments. On the other hand, these studies have a regional limitation and this review was not systematic. In conclusion, this narrative review may suggest that thermal water inhalations could be a promising option for managing patients with AR and RRIs, providing an alternative therapy with significant clinical benefits. Nevertheless, further high-quality, standardized, and international studies are necessary to confirm these findings and facilitate meta-analyses. These treatments could play a valuable role in reducing the burden of respiratory and allergic conditions.

过敏性鼻炎(AR)和复发性呼吸道感染(RRIs)是显著影响生活质量和医疗保健系统的常见疾病。由于其免疫调节和抗炎特性,热水吸入疗法已成为一种潜在的非药物选择。本综述旨在评价热水吸入治疗AR和RRIs患者的有效性和安全性。纳入标准是用英文撰写并发表在PubMed列出的期刊上的相关文章。在意大利进行的六项研究,涉及548名参与者(其中大多数是儿童和青少年),符合纳入标准。观察到鼻粘膜纤毛运输时间显著改善,各治疗组减少2至8分钟。总症状评分显著下降(一项研究报告减少了50%)。与对照组相比,治疗组上呼吸道感染的频率和持续时间大大减少。然而,鼻腔细胞学的结果不一致,研究设计的异质性限制了可比性。回顾的研究强调了热水疗法在增强纤毛粘膜清除、缓解症状和减少对其他药物治疗依赖方面的潜力。另一方面,这些研究存在区域局限性,本综述不系统。总之,这篇叙述性综述可能表明,热水吸入可能是治疗AR和RRIs患者的一种有希望的选择,提供了一种具有显着临床益处的替代疗法。然而,需要进一步的高质量、标准化和国际研究来证实这些发现并促进meta分析。这些治疗方法可以在减轻呼吸道和过敏疾病的负担方面发挥重要作用。
{"title":"Thermal water inhalation for allergic rhinitis and recurrent respiratory infections: a narrative review of the evidence.","authors":"Attilio Varricchio, Giulia Brindisi, Francesco Paolo Brunese, Maria Daglia, Giulio Dinardo, Lorenzo Drago, Alessandra Gori, Cristiana Indolfi, Matteo Naso, Enrico Tondina, Chiara Trincianti, Antonio Varricchio, Anna Maria Zicari, Michele Miraglia Del Giudice, Giorgio Ciprandi","doi":"10.1186/s13052-025-02133-1","DOIUrl":"10.1186/s13052-025-02133-1","url":null,"abstract":"<p><p>Allergic rhinitis (AR) and recurrent respiratory infections (RRIs) are common conditions that significantly impact quality of life and healthcare systems. Thermal water inhalation therapies have emerged as a potential non-pharmacological option due to their immunomodulatory and anti-inflammatory properties. This narrative review aimed to evaluate the efficacy and safety of thermal water inhalations in managing patients with AR and RRIs. The inclusion criteria were pertinent articles written in English and published in journals listed in PubMed. Six studies conducted in Italy, involving 548 participants (most of whom were children and adolescents), met the inclusion criteria. Significant improvements were observed in nasal mucociliary transport time, with reductions ranging from 2 to 8 min across treatment groups. Total Symptom Scores decreased significantly (one study reported a > 50% reduction). The frequency and duration of upper respiratory tract infections were reduced considerably in the treatment groups compared to the controls. However, results for nasal cytology were inconsistent, and heterogeneity in study designs limited comparability. The reviewed studies highlighted the potential of thermal water therapies to enhance mucociliary clearance, alleviate symptoms, and reduce reliance on other pharmacological treatments. On the other hand, these studies have a regional limitation and this review was not systematic. In conclusion, this narrative review may suggest that thermal water inhalations could be a promising option for managing patients with AR and RRIs, providing an alternative therapy with significant clinical benefits. Nevertheless, further high-quality, standardized, and international studies are necessary to confirm these findings and facilitate meta-analyses. These treatments could play a valuable role in reducing the burden of respiratory and allergic conditions.</p>","PeriodicalId":14511,"journal":{"name":"Italian Journal of Pediatrics","volume":"51 1","pages":"290"},"PeriodicalIF":3.1,"publicationDate":"2025-10-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12542181/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145344868","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Beckwith-Wiedemann spectrum (BWSp): an update on diagnosis, management, and follow-up from the scientific committee of the Italian BWSp association. Beckwith-Wiedemann谱(BWSp):意大利BWSp协会科学委员会关于诊断、管理和随访的最新信息。
IF 3.1 3区 医学 Q1 PEDIATRICS Pub Date : 2025-10-22 DOI: 10.1186/s13052-025-02131-3
Silvia Russo, Donatella Milani, Camilla Meossi, Lorenzo Marcucci, Roberta Pajno, Niccolò Butti, Guido Cocchi, Pierpaola Tannorella, Monica Bertoletti, Diana Carli, Maria Costanza Meazzini, Chiara Tortora, Mario Ferrari, Giuseppe Zampino, Stefania Massuras, Giovanni Battista Ferrero, Paola Quarello, Giulia Rossetti, Rosario Montirosso, Maurizio De Pellegrin, Andrea Riccio, Alessandro Mussa

Beckwith-Wiedemann spectrum (BWSp) is a congenital imprinting disorder characterized by overgrowth, cancer predisposition, and diverse clinical manifestations, resulting from epigenetic and genetic alterations at chromosome 11p15.5. BWSp represents the most common imprinting disorder, with a prevalence exceeding 1:10,000. The disorder is primarily associated with loss or gain of methylation at imprinting control regions IC2 and IC1, paternal uniparental disomy of 11p15, or pathogenic variants in CDKN1C. Advances in molecular diagnostics have refined genotype-phenotype correlations, improving both clinical management and tumor screening protocols. This review, produced by the Scientific Committee of the Italian BWSp Association (AIBWS), builds upon the 2018 international consensus, incorporating updated scientific evidence up to 2024. The committee critically assessed post-2017 literature using PRISMA and Delphi methodologies to revise ten key topics, including diagnosis and criteria, prenatal testing, molecular testing strategies, tumor surveillance, macroglossia surgery, growth monitoring, limb-length discrepancy, cognitive and psychosocial outcomes, and MLID (multi-locus imprinting disturbances). A major focus is optimizing diagnosis in cases with negative methylation tests on DNA from blood, where somatic mosaicism often necessitates alternative tissue testing. The review emphasizes prenatal diagnosis challenges, recommends including ART-related pregnancies in diagnostic criteria, and proposes a prenatal scoring system. Updated tumor surveillance strategies are presented, including universal α-fetoprotein screening for hepatoblastoma up to 3 years and genotype-based protocols for Wilms tumor. CDKN1C-related neuroblastoma surveillance is also addressed. MLID, often co-occurring with IC2-LoM, is discussed regarding clinical relevance, testing strategies, and implications for recurrence risk, particularly involving maternal-effect gene variants. Orthopedic and surgical management of limb-length discrepancy (LLD) and macroglossia is reviewed, alongside growth chart development and their role in personalized interventions. New findings on cognitive, behavioral, and psychosocial aspects highlight the need for routine screening and supportive care. The transition to adult care remains underexplored, though recommendations include attention to residual pediatric complications, fertility, and potential long-term risks. This review reinforces the importance of a multidisciplinary and personalized approach to BWSp across the lifespan, calling for further research to refine diagnostics, long-term outcomes, and transition models.

beckwithwithwiedemann spectrum (BWSp)是由11p15.5染色体的表观遗传和遗传改变引起的一种先天性印记疾病,其特征是过度生长、易患癌症,临床表现多样。BWSp是最常见的印记障碍,患病率超过1:10 000。该疾病主要与印迹控制区IC2和IC1甲基化的丧失或获得、11p15的父本单亲二体或CDKN1C的致病性变异有关。分子诊断技术的进步完善了基因型与表型的相关性,改善了临床管理和肿瘤筛查方案。该综述由意大利BWSp协会(AIBWS)科学委员会编制,以2018年的国际共识为基础,纳入了截至2024年的最新科学证据。委员会使用PRISMA和德尔福方法对2017年后的文献进行了批判性评估,以修订十个关键主题,包括诊断和标准、产前检测、分子检测策略、肿瘤监测、大舌骨手术、生长监测、肢体长度差异、认知和社会心理结果以及多位点印记障碍。一个主要的焦点是优化血液DNA甲基化测试阴性病例的诊断,其中体细胞嵌合体通常需要替代组织测试。该综述强调了产前诊断的挑战,建议将art相关妊娠纳入诊断标准,并提出了产前评分系统。提出了最新的肿瘤监测策略,包括对肝母细胞瘤进行为期3年的普遍α-胎儿蛋白筛查和基于基因型的肾母细胞瘤治疗方案。cdkn1c相关的神经母细胞瘤监测也被解决。MLID通常与IC2-LoM同时发生,本文讨论了其临床相关性、检测策略和复发风险的含义,特别是涉及母体效应基因变异。本文回顾了肢体长度差异(LLD)和大舌症的骨科和外科治疗,以及生长图表的发展及其在个性化干预中的作用。认知、行为和社会心理方面的新发现强调了常规筛查和支持性护理的必要性。向成人护理的过渡仍未得到充分探讨,尽管建议包括关注残余的儿科并发症、生育能力和潜在的长期风险。该综述强调了在整个生命周期内采用多学科和个性化方法治疗BWSp的重要性,并呼吁进一步研究以完善诊断、长期结果和过渡模型。
{"title":"Beckwith-Wiedemann spectrum (BWSp): an update on diagnosis, management, and follow-up from the scientific committee of the Italian BWSp association.","authors":"Silvia Russo, Donatella Milani, Camilla Meossi, Lorenzo Marcucci, Roberta Pajno, Niccolò Butti, Guido Cocchi, Pierpaola Tannorella, Monica Bertoletti, Diana Carli, Maria Costanza Meazzini, Chiara Tortora, Mario Ferrari, Giuseppe Zampino, Stefania Massuras, Giovanni Battista Ferrero, Paola Quarello, Giulia Rossetti, Rosario Montirosso, Maurizio De Pellegrin, Andrea Riccio, Alessandro Mussa","doi":"10.1186/s13052-025-02131-3","DOIUrl":"10.1186/s13052-025-02131-3","url":null,"abstract":"<p><p>Beckwith-Wiedemann spectrum (BWSp) is a congenital imprinting disorder characterized by overgrowth, cancer predisposition, and diverse clinical manifestations, resulting from epigenetic and genetic alterations at chromosome 11p15.5. BWSp represents the most common imprinting disorder, with a prevalence exceeding 1:10,000. The disorder is primarily associated with loss or gain of methylation at imprinting control regions IC2 and IC1, paternal uniparental disomy of 11p15, or pathogenic variants in CDKN1C. Advances in molecular diagnostics have refined genotype-phenotype correlations, improving both clinical management and tumor screening protocols. This review, produced by the Scientific Committee of the Italian BWSp Association (AIBWS), builds upon the 2018 international consensus, incorporating updated scientific evidence up to 2024. The committee critically assessed post-2017 literature using PRISMA and Delphi methodologies to revise ten key topics, including diagnosis and criteria, prenatal testing, molecular testing strategies, tumor surveillance, macroglossia surgery, growth monitoring, limb-length discrepancy, cognitive and psychosocial outcomes, and MLID (multi-locus imprinting disturbances). A major focus is optimizing diagnosis in cases with negative methylation tests on DNA from blood, where somatic mosaicism often necessitates alternative tissue testing. The review emphasizes prenatal diagnosis challenges, recommends including ART-related pregnancies in diagnostic criteria, and proposes a prenatal scoring system. Updated tumor surveillance strategies are presented, including universal α-fetoprotein screening for hepatoblastoma up to 3 years and genotype-based protocols for Wilms tumor. CDKN1C-related neuroblastoma surveillance is also addressed. MLID, often co-occurring with IC2-LoM, is discussed regarding clinical relevance, testing strategies, and implications for recurrence risk, particularly involving maternal-effect gene variants. Orthopedic and surgical management of limb-length discrepancy (LLD) and macroglossia is reviewed, alongside growth chart development and their role in personalized interventions. New findings on cognitive, behavioral, and psychosocial aspects highlight the need for routine screening and supportive care. The transition to adult care remains underexplored, though recommendations include attention to residual pediatric complications, fertility, and potential long-term risks. This review reinforces the importance of a multidisciplinary and personalized approach to BWSp across the lifespan, calling for further research to refine diagnostics, long-term outcomes, and transition models.</p>","PeriodicalId":14511,"journal":{"name":"Italian Journal of Pediatrics","volume":"51 1","pages":"287"},"PeriodicalIF":3.1,"publicationDate":"2025-10-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12542140/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145345196","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Macrolide-resistant Mycoplasma pneumoniae pneumonia in Chinese children: a retrospective study of clinical features and prognosis. 中国儿童大环内酯耐药肺炎支原体肺炎:临床特征和预后的回顾性研究。
IF 3.1 3区 医学 Q1 PEDIATRICS Pub Date : 2025-10-22 DOI: 10.1186/s13052-025-02137-x
Yu Zheng, Guitao Li, Hongchen Dai, Ying Zhu
{"title":"Macrolide-resistant Mycoplasma pneumoniae pneumonia in Chinese children: a retrospective study of clinical features and prognosis.","authors":"Yu Zheng, Guitao Li, Hongchen Dai, Ying Zhu","doi":"10.1186/s13052-025-02137-x","DOIUrl":"10.1186/s13052-025-02137-x","url":null,"abstract":"","PeriodicalId":14511,"journal":{"name":"Italian Journal of Pediatrics","volume":"51 1","pages":"289"},"PeriodicalIF":3.1,"publicationDate":"2025-10-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12542163/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145344942","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical features of MPP with or without viruses among hospitalized children in 2023, Wenzhou, Zhejiang, China. 2023年浙江省温州市住院儿童感染或不感染MPP的临床特征
IF 3.1 3区 医学 Q1 PEDIATRICS Pub Date : 2025-10-21 DOI: 10.1186/s13052-025-02128-y
Liya Chen, Haiyan Li, Peipei Zhong, Weikun Zheng, Hu Zhang, Suhua Li, Haifan Shi, Yiping Chen, Qi Liu
{"title":"Clinical features of MPP with or without viruses among hospitalized children in 2023, Wenzhou, Zhejiang, China.","authors":"Liya Chen, Haiyan Li, Peipei Zhong, Weikun Zheng, Hu Zhang, Suhua Li, Haifan Shi, Yiping Chen, Qi Liu","doi":"10.1186/s13052-025-02128-y","DOIUrl":"10.1186/s13052-025-02128-y","url":null,"abstract":"","PeriodicalId":14511,"journal":{"name":"Italian Journal of Pediatrics","volume":"51 1","pages":"286"},"PeriodicalIF":3.1,"publicationDate":"2025-10-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12542373/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145345222","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Specific plasma lipid species in children are causally associated with kawasaki disease: a mendelian randomization analysis. 儿童特定的血脂种类与川崎病有因果关系:一项孟德尔随机分析
IF 3.1 3区 医学 Q1 PEDIATRICS Pub Date : 2025-10-21 DOI: 10.1186/s13052-025-02126-0
Changqing Zhen, Shuo Zhang, Feng Guo
{"title":"Specific plasma lipid species in children are causally associated with kawasaki disease: a mendelian randomization analysis.","authors":"Changqing Zhen, Shuo Zhang, Feng Guo","doi":"10.1186/s13052-025-02126-0","DOIUrl":"10.1186/s13052-025-02126-0","url":null,"abstract":"","PeriodicalId":14511,"journal":{"name":"Italian Journal of Pediatrics","volume":"51 1","pages":"285"},"PeriodicalIF":3.1,"publicationDate":"2025-10-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12538993/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145344873","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ceftriaxone-induced cholelithiasis in pediatrics: pooled frequency, symptoms, and associated factors - systematic review and meta-analysis. 头孢曲松所致儿科胆石症:合并频率、症状和相关因素——系统评价和荟萃分析
IF 3.1 3区 医学 Q1 PEDIATRICS Pub Date : 2025-10-10 DOI: 10.1186/s13052-025-02057-w
Tahneem Yaseen, Khurshid Alam, Mohammed Zawiah, Amal K Suleiman, Amer Hayat Khan

Ceftriaxone is commonly used in pediatric infections, but its association with cholelithiasis poses potential health concerns. To determine the pooled frequency of ceftriaxone-induced cholelithiasis in pediatric patients and identify factors commonly associated with its occurrence. Web of Science, PubMed, Google Scholar, and Scopus were systematically searched until March 2024.Studies reporting ceftriaxone-induced cholelithiasis in pediatric patients (0-18 years) were included. Randomized controlled trials (RCTs) and prospective and retrospective cohort studies published in English were eligible. PRISMA guidelines were followed. The Newcastle‒Ottawa Scale and CASP tools were used to assess risk of bias. A random-effects meta-analysis estimated the pooled frequency. Sensitivity analysis was conducted to explore heterogeneity. The primary outcome was the pooled frequency of ceftriaxone-induced cholelithiasis. Secondary outcomes included identification of factors commonly associated with its occurrence and their impact on symptom burden. Eleven studies (1 RCT, 10 cohort studies) met the inclusion criteria. The pooled frequency of cholelithiasis was 15% (95% CI: 9-23%), with significant heterogeneity (I² = 81.76%). Commonly associated factors included high ceftriaxone doses (> 2 g/day), prolonged use (> 5 days), short bolus injections, and dehydration. Most cases resolved upon discontinuation, but symptomatic patients experienced nausea, vomiting, and abdominal pain. Ceftriaxone-induced cholelithiasis is relatively common in pediatric patients, particularly those with associated risk factors. Clinicians should monitor for biliary complications and consider alternative treatments when feasible. PROSPERO REGISTRATION: CRD42024503807.

头孢曲松通常用于儿科感染,但其与胆石症的关联带来了潜在的健康问题。目的:确定头孢曲松所致儿科患者胆石症的总发生率,并确定其发生的常见相关因素。Web of Science, PubMed, b谷歌Scholar和Scopus被系统地检索到2024年3月。研究报告头孢曲松诱导胆石症儿童患者(0-18岁)。随机对照试验(rct)和前瞻性和回顾性队列研究发表的英文符合条件。遵循PRISMA准则。使用纽卡斯尔-渥太华量表和CASP工具评估偏倚风险。随机效应荟萃分析估计了合并频率。进行敏感性分析以探讨异质性。主要终点是头孢曲松诱导的胆石症的合并频率。次要结局包括确定与其发生相关的因素及其对症状负担的影响。11项研究(1项RCT, 10项队列研究)符合纳入标准。胆石症合并发生率为15% (95% CI: 9-23%),异质性显著(I²= 81.76%)。常见的相关因素包括高头孢曲松剂量(10 ~ 2 g/天)、长时间使用(10 ~ 5天)、短剂量注射和脱水。大多数病例停药后痊愈,但有症状的患者出现恶心、呕吐和腹痛。头孢曲松诱导的胆石症在儿科患者中相对常见,特别是那些有相关危险因素的患者。临床医生应监测胆道并发症,并在可行时考虑其他治疗方法。普洛斯彼罗注册:crd42024503807。
{"title":"Ceftriaxone-induced cholelithiasis in pediatrics: pooled frequency, symptoms, and associated factors - systematic review and meta-analysis.","authors":"Tahneem Yaseen, Khurshid Alam, Mohammed Zawiah, Amal K Suleiman, Amer Hayat Khan","doi":"10.1186/s13052-025-02057-w","DOIUrl":"10.1186/s13052-025-02057-w","url":null,"abstract":"<p><p>Ceftriaxone is commonly used in pediatric infections, but its association with cholelithiasis poses potential health concerns. To determine the pooled frequency of ceftriaxone-induced cholelithiasis in pediatric patients and identify factors commonly associated with its occurrence. Web of Science, PubMed, Google Scholar, and Scopus were systematically searched until March 2024.Studies reporting ceftriaxone-induced cholelithiasis in pediatric patients (0-18 years) were included. Randomized controlled trials (RCTs) and prospective and retrospective cohort studies published in English were eligible. PRISMA guidelines were followed. The Newcastle‒Ottawa Scale and CASP tools were used to assess risk of bias. A random-effects meta-analysis estimated the pooled frequency. Sensitivity analysis was conducted to explore heterogeneity. The primary outcome was the pooled frequency of ceftriaxone-induced cholelithiasis. Secondary outcomes included identification of factors commonly associated with its occurrence and their impact on symptom burden. Eleven studies (1 RCT, 10 cohort studies) met the inclusion criteria. The pooled frequency of cholelithiasis was 15% (95% CI: 9-23%), with significant heterogeneity (I² = 81.76%). Commonly associated factors included high ceftriaxone doses (> 2 g/day), prolonged use (> 5 days), short bolus injections, and dehydration. Most cases resolved upon discontinuation, but symptomatic patients experienced nausea, vomiting, and abdominal pain. Ceftriaxone-induced cholelithiasis is relatively common in pediatric patients, particularly those with associated risk factors. Clinicians should monitor for biliary complications and consider alternative treatments when feasible. PROSPERO REGISTRATION: CRD42024503807.</p>","PeriodicalId":14511,"journal":{"name":"Italian Journal of Pediatrics","volume":"51 1","pages":"284"},"PeriodicalIF":3.1,"publicationDate":"2025-10-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12512820/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145274690","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pediatric stewardship in Italy: a necessity, not an option - a National Multi-Society Expert Consensus on Antimicrobial and Diagnostic Stewardship (SIP, SITIP, SIMRI, SIAIP, SIMEUP, SIPPS, SICUPP, SIMIT, SIMPE, SIPINF, SIT, SIAATIP, SARNEPI, AIEOP, SIM, SITI, SIF, SIFACT, SITA, SIN). 意大利的儿科管理:是必要的,而不是可选的——关于抗菌和诊断管理的全国多协会专家共识(SIP、SITIP、SIMRI、SIAIP、SIMEUP、SIPPS、SICUPP、SIMIT、SIMPE、SIPINF、SIT、SIAATIP、SARNEPI、AIEOP、SIM、SITI、SIF、SIFACT、SITA、SIN)。
IF 3.1 3区 医学 Q1 PEDIATRICS Pub Date : 2025-10-09 DOI: 10.1186/s13052-025-02112-6
Daniele Dona, Elisa Barbieri, Giulia Brigadoi, Martina Barchitta, Alberto Berardi, Samantha Bosis, Sara Buchini, Danilo Buonsenso, Andrea Cagliero, Beatrice Rita Campana, Fabio Capello, Romeo Carrozzo, Elio Castagnola, Salvatore Cazzato, Simone Cesaro, Elena Chiappini, Claudia Colomba, Manola Comar, Alessandra De Alessandri, Maia De Luca, Barnaba Esposito, Maria Rosaria Filograna, Alessia Franceschi, Luisa Galli, Silvia Garazzino, Fabrizio Gemmi, Emelyne Gres, Laura Lancella, Cecilia Liberati, Andrea Lo Vecchio, Milena Lo Giudice, Gianluigi Marseglia, Gaia Martelli, Daniele Mengato, Stefania Mercadante, Marianna Meschiari, Michele Miraglia Del Giudice, Carlotta Montagnani, Paola Muggeo, Giangiacomo Nicolini, Stefania Nobili, Federico Pea, Dino Pedrotti, Lamberto Reggiani, Vittorio Sambri, Maurizio Sanguinetti, Alessandra Santiloni, Maria Chiara Silvani, Luisa Vatiero, Daniele Zama, Stefania Zampogna, Rosanna Zanai, Susanna Esposito

Antimicrobial Stewardship Programs (ASPs) and Diagnostic Stewardship Programs (DSPs) are essential for optimizing infectious disease management and addressing antimicrobial resistance (AMR). However, the implementation of pediatric ASPs presents distinct challenges that set them apart from adult-focused initiatives. Additionally, many existing ASP guidelines are primarily tailored to the U.S. healthcare system, requiring significant adaptation to fit the diverse healthcare infrastructures, resources, and prescribing practices across different countries. These factors highlight the need for context-specific strategies to ensure the effective implementation of pediatric ASPs worldwide. To develop a national, intersociety consensus on pediatric ASPs in Italy, an ASP steering committee was established, bringing together a multidisciplinary group of experts. A systematic scoping review was conducted to identify relevant literature on ASPs and DSPs published between 2007 and August 2024, retrieving 260 articles. Based on this evidence, 33 recommendations were formulated, covering general ASP and DSP principles (10 recommendations), ASP interventions (14), DSP interventions (3), and monitoring strategies (6). Consensus on the importance and feasibility of each recommendation was reached using the Delphi method, with two rounds of anonymous questionnaires. The steering group defined a priori criteria for recommendation acceptance, requiring at least 80% agreement on the importance of each item. This consensus highlights the critical role of a multidisciplinary approach in ASP implementation, supported by institutional leadership. Given the variability in healthcare systems, ASP interventions must be tailored to specific settings, considering factors such as hospital resources, patient complexity, and the parent-child dynamic. Standardized metrics for assessing the impact of ASPs are essential for benchmarking and ensuring sustainability, although data collection remains a significant challenge. While there was strong agreement on the importance of the recommendations, feasibility assessments identified key areas requiring further refinement, particularly in settings with limited pediatric-specific expertise and diagnostic tools. This national consensus provides a structured framework for the implementation of pediatric ASPs in Italy, equipping clinicians with essential tools to optimize antibiotic use in both inpatient and outpatient settings. It represents a foundational step toward improving pediatric ASP, fostering national and international collaboration, and guiding future research to address implementation barriers.

抗菌素管理计划(asp)和诊断管理计划(dsp)对于优化传染病管理和解决抗菌素耐药性(AMR)至关重要。然而,儿科asp的实施提出了明显的挑战,使他们有别于成人为重点的举措。此外,许多现有的ASP指南主要是针对美国医疗保健系统量身定制的,需要进行重大调整,以适应不同国家不同的医疗保健基础设施、资源和处方实践。这些因素突出表明,需要针对具体情况制定战略,以确保在全球范围内有效实施儿科asp。为了在意大利就儿科ASP达成全国性、跨社会共识,成立了ASP指导委员会,汇集了多学科专家组。对2007年至2024年8月间发表的asp和dsp相关文献进行了系统的范围综述,检索了260篇文章。基于这些证据,我们制定了33项建议,包括ASP和DSP的一般原则(10项建议)、ASP干预措施(14项)、DSP干预措施(3项)和监测策略(6项)。采用德尔菲法,通过两轮匿名问卷对各建议的重要性和可行性达成共识。指导小组定义了接受建议的先验标准,要求每个项目的重要性至少有80%的一致性。这一共识强调了在机构领导的支持下,多学科方法在ASP实施中的关键作用。鉴于医疗保健系统的可变性,ASP干预措施必须根据具体情况量身定制,考虑医院资源、患者复杂性和亲子动态等因素。尽管数据收集仍然是一个重大挑战,但用于评估asp影响的标准化指标对于制定基准和确保可持续性至关重要。虽然对建议的重要性达成了强烈共识,但可行性评估确定了需要进一步完善的关键领域,特别是在儿科专业知识和诊断工具有限的情况下。这一全国性共识为意大利儿科asp的实施提供了一个结构化框架,为临床医生提供了基本工具,以优化住院和门诊环境中的抗生素使用。它代表着朝着提高儿科ASP、促进国家和国际合作、指导未来研究以解决实施障碍迈出的基础性一步。
{"title":"Pediatric stewardship in Italy: a necessity, not an option - a National Multi-Society Expert Consensus on Antimicrobial and Diagnostic Stewardship (SIP, SITIP, SIMRI, SIAIP, SIMEUP, SIPPS, SICUPP, SIMIT, SIMPE, SIPINF, SIT, SIAATIP, SARNEPI, AIEOP, SIM, SITI, SIF, SIFACT, SITA, SIN).","authors":"Daniele Dona, Elisa Barbieri, Giulia Brigadoi, Martina Barchitta, Alberto Berardi, Samantha Bosis, Sara Buchini, Danilo Buonsenso, Andrea Cagliero, Beatrice Rita Campana, Fabio Capello, Romeo Carrozzo, Elio Castagnola, Salvatore Cazzato, Simone Cesaro, Elena Chiappini, Claudia Colomba, Manola Comar, Alessandra De Alessandri, Maia De Luca, Barnaba Esposito, Maria Rosaria Filograna, Alessia Franceschi, Luisa Galli, Silvia Garazzino, Fabrizio Gemmi, Emelyne Gres, Laura Lancella, Cecilia Liberati, Andrea Lo Vecchio, Milena Lo Giudice, Gianluigi Marseglia, Gaia Martelli, Daniele Mengato, Stefania Mercadante, Marianna Meschiari, Michele Miraglia Del Giudice, Carlotta Montagnani, Paola Muggeo, Giangiacomo Nicolini, Stefania Nobili, Federico Pea, Dino Pedrotti, Lamberto Reggiani, Vittorio Sambri, Maurizio Sanguinetti, Alessandra Santiloni, Maria Chiara Silvani, Luisa Vatiero, Daniele Zama, Stefania Zampogna, Rosanna Zanai, Susanna Esposito","doi":"10.1186/s13052-025-02112-6","DOIUrl":"10.1186/s13052-025-02112-6","url":null,"abstract":"<p><p>Antimicrobial Stewardship Programs (ASPs) and Diagnostic Stewardship Programs (DSPs) are essential for optimizing infectious disease management and addressing antimicrobial resistance (AMR). However, the implementation of pediatric ASPs presents distinct challenges that set them apart from adult-focused initiatives. Additionally, many existing ASP guidelines are primarily tailored to the U.S. healthcare system, requiring significant adaptation to fit the diverse healthcare infrastructures, resources, and prescribing practices across different countries. These factors highlight the need for context-specific strategies to ensure the effective implementation of pediatric ASPs worldwide. To develop a national, intersociety consensus on pediatric ASPs in Italy, an ASP steering committee was established, bringing together a multidisciplinary group of experts. A systematic scoping review was conducted to identify relevant literature on ASPs and DSPs published between 2007 and August 2024, retrieving 260 articles. Based on this evidence, 33 recommendations were formulated, covering general ASP and DSP principles (10 recommendations), ASP interventions (14), DSP interventions (3), and monitoring strategies (6). Consensus on the importance and feasibility of each recommendation was reached using the Delphi method, with two rounds of anonymous questionnaires. The steering group defined a priori criteria for recommendation acceptance, requiring at least 80% agreement on the importance of each item. This consensus highlights the critical role of a multidisciplinary approach in ASP implementation, supported by institutional leadership. Given the variability in healthcare systems, ASP interventions must be tailored to specific settings, considering factors such as hospital resources, patient complexity, and the parent-child dynamic. Standardized metrics for assessing the impact of ASPs are essential for benchmarking and ensuring sustainability, although data collection remains a significant challenge. While there was strong agreement on the importance of the recommendations, feasibility assessments identified key areas requiring further refinement, particularly in settings with limited pediatric-specific expertise and diagnostic tools. This national consensus provides a structured framework for the implementation of pediatric ASPs in Italy, equipping clinicians with essential tools to optimize antibiotic use in both inpatient and outpatient settings. It represents a foundational step toward improving pediatric ASP, fostering national and international collaboration, and guiding future research to address implementation barriers.</p>","PeriodicalId":14511,"journal":{"name":"Italian Journal of Pediatrics","volume":"51 1","pages":"283"},"PeriodicalIF":3.1,"publicationDate":"2025-10-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12512260/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145258274","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Italian Journal of Pediatrics
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1